Aimery de Gramont

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 434 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Prognostic Impact of Positive Surgical Margins After Resection of Colorectal Cancer Liver Metastases: Reappraisal in the Era of Modern Chemotherapy

Hadrien Tranchart, Mircea Chirica, Matthieu Faron et al. · World Journal of Surgery · 2013 · 62 citations

Medicine, Oncology, Surgery +17

Adoptive Immunotherapy with Activated Macrophages Grown In Vitro from Blood Monocytes in Cancer Patients

M. Lopez, J. Fechtenbaum, B. David et al. · Journal of Immunotherapy · 1992 · 59 citations

Life Sciences, Immunology, Oncology +17

Could baseline health-related quality of life (QoL) predict overall survival in metastatic colorectal cancer? The results of the GERCOR OPTIMOX 1 study

Momar Diouf, Benoist Chibaudel, Thomas Filleron et al. · Health and Quality of Life Outcomes · 2014 · 33 citations · Full text

Medicine, Oncology, Chemotherapy +16

Acquisition of a Philadelphia chromosome concomitant with transformation of a refractory anemia into an acute leukemia

N Smadja, M Krulik, Aimery de Gramont et al. · Cancer · 1985 · 23 citations

Medicine, Hematology, Oncology +17